GSK slapped with 'sell' rating over long-term risks | LSE:GSK, NYSE:GSK
GSK: Glaxo SmithKline Share Price Target 2023, 2025, 2027, 2030 to 2050 - Sharedhan
GSK plc - Wikipedia
GSK to sell 2.9% stake in former consumer healthcare business Haleon | Reuters
GSK To Sell Poznań Manufacturing Site To Delpharm | Contract Pharma
Glaxo plots £8bn move to buy back Beechams stake
Should You Sell GlaxoSmithKline plc (LON:GSK) At This PE Ratio?
A GSK Dividend Cut Is Imminent - Should I Sell GlaxoSmithKline? - TEV
Glenmark Pharma & GSK Pharma: Top Stock Recommendation From Aditya Arora | ET Now - YouTube
GSK plans to sell stake in Unilever's India unit: Report
GSK bets on cough drug with $2bn deal for Canadian biotech
GSK Consumer Healthcare's Horlicks sale could prove to be a sticky attraction for some | Mint
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK - MarketWatch
GSK-HUL deal: HUL shares gain after Horlicks deal; should you buy or sell stock? What brokerages say - Market News | The Financial Express
Buy, Sell or Hold: GlaxoSmithKline PLC (GSK-N) — Stock Predictions at Stockchase
The trading activity of the stock GSK between the 26500 − 28500'th... | Download Scientific Diagram
FTSE 100: GSK Reaches Settlement in Zantac Lawsuit | Markets Insider
Why GSK had to sell its Indian consumer health business
GlaxoSmithKline to leave landmark global HQ after split-up as consumer health business plots £120M new home | Fierce Pharma
With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional owners - Simply Wall St News
GSK Raises $1 Billion Selling Shares in Haleon Spinoff - Bloomberg
GlaxoSmithKline and Pfizer to Merge Consumer Health Units - The New York Times
GSK (GSK) Stock Price, News & Info | The Motley Fool
GSK Lifts Annual Outlook as Q3 Vaccine Sales Soar - TipRanks.com
Pfizer to sell stake in GSK consumer health joint venture after spinoff | HealthCare Middle East & Africa Magazine
With $1.2B stock sale, GSK offloads more of its stake in consumer health spinoff Haleon | Fierce Pharma
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BWRRND7NK5ORFONQ4YXBCQPDTU.jpg "GSK raises $1.24 bln from latest Haleon stake sale | Reuters")
GSK raises $1.24 bln from latest Haleon stake sale | Reuters
